Trabeculectomy + MMC Audit Mark Chiang, Clinical Research Fellow Mr. Peter Shah, Consultant Ophthalmic Surgeon Good Hope Hospital.

Slides:



Advertisements
Similar presentations
Outcome of 23-gauge sutureless transconjunctival vitrectomy for endophthalmitis Dr Colin S.H. Tan.
Advertisements

CATARACT SUEGRY AND DIABETES Indications of surgery: 1) Visual loss 2)Surveillance of retinopathy 3)Laser therapy.
EX-PRESS® Device in Clinical Practice New York September, 2011 Marlene R. Moster MD Professor of Ophthalmology Thomas Jefferson School of Medicine Wills.
Use of a Novel Y- Suture Technique to Reduce Detachments in Descemet’s Stripping Automated Endothelial Keratoplasty (DSAEK) Habeeb Ahmad, MD Martin Heur,
Bleb leak characteristics and success of repair following trabeculectomy with Mitomycin C Amy Hennessy, MD MPH Harold Bernstein, MD Medical College of.
CATARACT ASSESSMENT Cataract: opacity of the lens Population at risk: greater than 70 years old S&S: blurred vision.
Phacoemulsification with Goniosynechialysis in the Management of Refractory Acute Angle-closure Glaucoma Ghasem Fakhraie*, MD, Mahmoud Jabbarvand, MD,
Boston Type I Keratoprosthesis and Silicone Oil for the Treatment of Hypotony in Prephthisis Kristiana D. Neff 1, William I. Sawyer 2, Michael R. Petersen.
J.Talajic, K. Miszkiewicz, L. Racine, M. Harissi-Dagher The authors have no financial interest in the subject matter of this poster. Fibrin Glue versus.
Contrast-Enhanced Corneal Wound Imaging by Optical Coherence Tomography Preeya K. Gupta, MD Justis P. Ehlers, MD Terry Kim, MD Duke Eye Center, Durham,
9/5/20151 Surgical Therapy in Glaucoma 2014 J. James Thimons, O.D.,FAAO Ophthalmic Consultants of Connecticut Fairfield, CT.
April 15-17, 2015 World Cornea Congress VII San Diego, California
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Trabeculectomy for Open-Angle Glaucoma Takihara Y, Inatani M, Ogata-Iwao M, et.
Glaucoma Surgery 2011: Why am I Still Doing a Trabeculectomy? Garry P Condon, MD Associate Professor Ophthalmology Drexel University College of Medicine.
TARIQ ALASBALI WHICH PATIENTS ARE AT RISK FOR THE PROGRESSION?
Purpose: Introduction:  At initial evaluation: For post-op day # 0 patients: Pre-op VA was 20/50.6 (0.395 ± 0.198); Post-op VA was 20/102.0 (0.196 ± 0.162);
OCULAR HYPERTENSION AFTER PENETRATING KERATOPLASTY F Orucov, E Strassman, D Landau, J Frucht-Pery and A Solomon, Department of Ophthalmology, Hadassah-Hebrew.
South Hills Eye Associates
A TOUR OF THE WORLD OF GLAUCOMA SURGERY Dr. Jennifer Fan Gaskin Glaucoma Specialist.
>>0 >>1 >> 2 >> 3 >> 4 >> FULL PANRETINAL PHOTOCOAGULATION IMPROVES THE OUTCOME OF TRABECULECTOMY IN NEOVASCULAR GLAUCOMA Saleh alobeidan MD Essam osman.
Satinder Pal Singh Grewal MD
HEFT Audit Nov 2008 Trabeculectomy + Antiscarring Mitomycin C Prof Peter Shah Mr Aruna Dharmasena Dr Freda Sii.
OCULAR FEATURES OF VERNAL KERATOCONJUNCTIVITIS IN CHILDREN REQUIRING TRABECULECTOMY WITH MITOMYCIN-C FOR STEROID-INDUCED GLAUCOMA CORDELIA CHAN FRCSEd.
Cataract Surgery After Trabeculectomy: The Effect on Trabeculectomy Function Husain R, Liang S, Foster PJ. Cataract surgery after trabeculectomy: the effect.
Riley Hall BSc α, Robert Mitchell MD, FRCSC β University of Saskatchewan α, University of Calgary β Authors have no financial interest Comparison of postoperative.
“OUR EXPERIENCE OF SECONDARY IOLS - SCLERAL FIXATION v/sAC IOL DR. RUPAM DESAI ROTARY EYE INSTITUTE NAVSARI INDIA (Author has no financial interest)
Effect of Corneal Thickness on Selective Laser Trabeculoplasty to Decrease Intraocular Pressure as Primary or Secondary Treatment of Glaucoma ASCRS 2010.
AlphaCor TM : A Novel Approach to Minimize Late Post-operative Complications V. Ngakeng MD, M. Price PhD. MBA, F. Price MD.
Young Joo Shin, 1 Sang Mok Lee, 2 Jin Choi, 3 Eun Ryung Han, 4 Dong Hae Kim 4 1 H ally m University Gangnam Sacred Heart Hospital 2 3The Armed Forces Medical.
Combined Phacoemulsification and Ahmed Glaucoma Drainage Implant Surgery Leonidas Traipe, M.D. Felipe Valenzuela, M.D. Carlos Nieme, M.D Juan Stoppel,
Approaches to prevention and management of Trabeculectomy Complications Moaz Suleiman.
Subtenon’s Anesthesia in Pterygium Excision with Conjunctival Autograft Michael R. Gagnon, M.D. Clinical Instructor, Stanford University Valley EyeCare.
V Dilraj Grewal MD SPS Grewal MD Rajeev Jain, MD G S Brar MD Evaluation of Sub-Conjunctival Bevacizumab as an antiproliferative agent in Glaucoma Filtering.
Introduction  Selective Laser Trabeculoplasty (SLT) uses a Q-Switched frequency- doubled (532 nm), low energy Nd:YAG laser, which targets melanocytes.
Combined cataract surgery and endoscopic cyclophotocoagulation in patients with glaucoma without prior incisional glaucoma surgery Matthew P. Traynor,
PHACO-TRAB VERSUS PHACO ONLY IN EYES WITH ADVANCED OR END-STAGE GLAUCOMA WITH CONTROLLED INTRAOCULAR PRESSURE AND VISUALLY SIGNIFICANT CATARACT Liaska.
LD - 74 yo woman Bleb revision Left eye for hypotony - March 2014 Conjunctiva incised 1 mm posterior to avascular bleb Mobilized conjunctiva posteriorly.
Advanced Glaucoma and Cataract: Management Options Regenbogen Michael – Ichilov Amer Radgonde – Hadassah Ron Yonina – Beilinson Reyvitch Svetlana – Barsilai.
Efficacy and Safety of the Ex-PRESS Glaucoma Mini-Shunt with Intraoperative 5-Fluorouracil ASCRS 2009 – San Francisco A. Balashanmugam, MD, L. Farrokh-Siar,
Jodhbir S Mehta, Donald Tan The Authors have a financial Interest in the Endoglide patent/royalty.
Two Cases of Subconjunctival Bevacizumab Injection to Prevent Bleb Failure after Trabeculectomy Dongwook Lee, Min Ahn, In-Cheon You, Daegyu Lee Chonbuk.
Descemet’s stripping automated endothelial keratoplasty by novice endothelial keratoplasty surgeons Jason W. Much, M.D. 1 Paul M. Phillips, M.D. 1,2 Leslie.
Evidence-Based Target Pressures Paul Palmberg, MD, PhD Bascom Palmer Eye Institute University of Miami School of Medicine How to Achieve Low Target Pressures.
Descemet’s Stripping Endothelial Keratoplasty (DSEK) in patients with prior Trabeculectomy or Tube shunt surgery. Thadani S.M. Fynn-Thompson N. Authors.
Mr. A. Waldock MD BMed Sci (Hons) BM BS FRCOphth Consultant Ophthalmic Surgeon Ophthalmology Training Programme Director, East of England Deanery.
Russ Trenary President & CEO
D.r Nishant Nawani, MS Dr. Surinder Singh Pandav, MD Dr. Amit Gupta, MD Dr. Sushmita Kaushik, MD Advanced Eye Centre PGIMER, Chandigarh The authors have.
V. Kumar 1,2, M. Frolov 1, I. Shepelova 1,2 Department of ophthalmology, People's friendship university of Russia, Moscow, Russian Federation 1 ; Ophthalmic.
EFFICACY OF SUBCONJUCTIVAL BEVACIZUMAB ASSOCIATED TO MITOMYCIN-C ON GLAUCOMA FILTERING SURGERY. Juan Carlos Mesa-Gutiérrez, MD, PhD, FEBOphth, FICOphth.
iStent with phacoemulsification, n=50
Pseudoexfoliation syndrom and cataract: results and complication frequency in immature and mature cataract surgery Marijana Bilen Babić Department of.
NonPenetrating Glaucoma Surgery
COMBINED PHACOEMULSIFICATION AND TRANS-SCLERAL CYCLOPHOTOCOAGULATION
IMPACT OF CATARACT SURGERY UPON INTRAOCULAR PRESURE CONTROL IN GLAUCOMA PATIENTS Crenguta Feraru, Anca Pantalon “Gr.T. Popa” University of Medicine and.
LONG-TERM RESULTS OF DEEP SCLERECTOMY IN NORMAL-TENSION GLAUCOMA
Selective laser trabeculoplasty in Korean eyes with medically uncontrolled pseudoexfoliation glaucoma Su Chan Lee1, Jung Hyun Lee1,
V. Kumar,1,2 M. Frolov,1 E. Bozhok,2 G. Dushina1
Trauma z Surgical treatment of extremely complicated forms of glaucoma
A NEW INTRACANALICULAR DEVICE TO TREAT OPEN-ANGLE GLAUCOMA
TRABECULECTOMY Saleh Al Obeidan, MD Department of Ophthalmology
Preoperative Characteristics
Frolov Mikhail, Dushina Galina
Advancing Gynaecological Surgery:
NonPenetrating Glaucoma Surgery
Clinical study of open angle glaucoma surgery treatment trough deep slerectomy with T-Flux NV implant: three years follow-up Dr. Marco Rossi Dr Michele.
Prospective Randomized Trial Comparing Mitomycin C Combined with Ologen Implant versus Mitomycin C Alone as Adjuvants in Trabeculectomy  Mrittika Sen,
DW.Lee, NC Cho, MJ Kim, EY Kwen
A presentation to: Meeting name Date
Results of corrective surgery: secondary lens implantation at a cataract surgery training centre Mehul Shah,shreya shah, adway appalware,pramod upadhyay,
Japanese Red Cross Society
Presentation transcript:

Trabeculectomy + MMC Audit Mark Chiang, Clinical Research Fellow Mr. Peter Shah, Consultant Ophthalmic Surgeon Good Hope Hospital

Aim To assess success and complication rates of trabeculectomies augmented with mitomycin C To compare results to the National Trabeculectomy Survey To define the characteristics of patients undergoing trabeculectomy with MMC

Methods Prospective database of consecutive patients undergoing trabeculectomy + MMC under care of Mr. Peter Shah Data collected Demographics Pre-operative, operative and follow-up data

Results Total number of eyes = 123Total number of eyes = 123 Note retrieval 100%Note retrieval 100% 2004 Data update 99%2004 Data update 99%

Gender

Age at surgery Mean age = 55.6 years

Ethnicity

Glaucoma type

Pre-op medications Average no. of drops = 2.65 (36.6% on Diamox)

Surgeons

Intraocular pressures (pre-operative) HTG (108 eyes)NTG (15 eyes) Mean pre-op highest IOP 38.0 mmHg18.5 mmHg Mean pre-op IOP 24.1 mmHg15.7 mmHg

Intraocular pressures (post-operative) HTGNTG Mean IOP (1 year) 12.9 mmHg11.3 mmHg % IOP drop (1 year) 46.5%28.0% Mean IOP (latest follow-up) 13.0 mmHg10.6 mmHg % IOP drop (latest follow-up) 46.1%32.5%

IOP distribution (1 year)

Overall success (latest follow-up – mean 613 days) HTG (106 eyes)NTG (14 eyes) IOP ≤ % IOP ≤ %100% IOP ≤ %100% IOP reduction > 30% 71.7%57.1%

Success by ethnicity (1 year) AFC (23)Caucasian (59) IOP ≤ % (78.3%)98.3% IOP ≤ % (78.3%)94.9% IOP ≤ %86.4% IOP reduction > 30% 65.2%78.0%

Success by previous surgery (1 year) None (58)Intraocular (24) IOP ≤ % (96.6%)91.7% (90.9%) IOP ≤ % (96.6%)75% IOP ≤ %54.2% IOP reduction > 30% 75.9%70.8%

Bleb morphology (1 year) Excellent bleb morphology 75.0%

Bleb morphology (1 year) Satisfactory morphology 21.4%

Bleb morphology (1 year) Poor morphology 3.6%

Bleb Needling Revision 13.8% of patients (17/123) 64.7% males Mean pre-op highest IOP 40.7 mmHg 47.1% on Diamox pre-operatively 47.1% had previous intraocular surgery 41.2% required topical drops at latest follow-up 35.3% African-Caribbean

Post-op management

Complications

Clinically Significant Early Hypotony (CSEH) 4.9% of patients Required intervention Viscoelastic to AC Conjunctival / scleral flap suturing Analysis of CSEH reveals: 33.3% AFC 66.7% < 45 years of age

Follow-up failures (DNA) DNA in 6 patients during follow-up 4 African-Caribbean 2 Caucasian – 1 alcoholic / 1 psychiatric 5 males Mean age 45.7 years old Age < 45 Male African-Caribbean ethnicity

Surgery technique Fornix based conjunctival flap Wide sub-Tenons treatment with MMC (0.1 – 0.2 mg/ml for 1 – 3 mins) Pre-placed, buried, releasable ± adjustable scleral flap sutures Intra-op IOP titration Buried purse-string & mattress closure of conjunctiva and Tenons

Conclusion High success rates for this series Low complication rates for this series Results exceed National Trabeculectomy Survey Complications are more common in African-Caribbean patients and in young patients

Summary Success 97.2% Sight threatening complications 0.8% 0 Wipe-out 0 Endophthalmitis 0 Suprachoroidal haemorrhage 1 Late hypotony Clinically Significant Early Hypotony (requiring intervention) 4.9%

National Trabeculectomy Survey Success, IOP < 21 – 92% Complications Hypotony – 24.3% Hypotony maculopathy – 0.2% Endophthalmitis – 0.3% Wipe-out – 0.4% of total cohort, 5% in advanced glaucoma Cataract needing extraction – 2.5%

Other series Success – 80 – 90% Complications Hypotony – 4.8 – 47% Hypotony maculopathy – 4 – 12% Blebitis – 2 – 5.7% Endophthalmitis – 0.8 – 8% Wipe-out – 25% in one series Cataract needing operation during follow-up – 12 – 55%

BUT!!

It’s only possible with Good pre-operative, peri-operative and intensive post-operative care Good success with lower doses of MMC but 34% post-op 5-FU and 14% bleb needling revision

Trabeculectomy with MMC is a complex operation requiring high degree of manual dexterity and extensive glaucoma experience Suggest Fellowship training for all surgeons performing this operation With close Consultant supervision, high success rates for Fellows in training Discussion points

Actions Continue long-term analysis of series Target African-Caribbean and JOAG patients for intensive intervention Improve patient information Consider glaucoma support nurse help These results only possible with continued Fellow support

Pearls Identify thin tissues pre-op Small peritomy Stromal hydration Careful closure ? No MMC Thin Tissues + Leak = Early Failure

In AFC / thick tissues need early (<10 days) high flow into sub-Tenon space May need to remove both releasables Pearls

Thin conj and Tenons – need thick scleral flap to control aqueous outflow Pearls

JOAGs get hypotony Need early surgical intervention Beware of the young! Pearls